πŸ‡ΊπŸ‡Έ FDA
Patent

US 11040090

Botulinum neurotoxin compositions

granted A61KA61K31/165A61K31/167

Quick answer

US patent 11040090 (Botulinum neurotoxin compositions) held by Prime Bio, Inc. expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Prime Bio, Inc.
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/165, A61K31/167, A61K38/4893, A61K45/06